CRC Credit Research Compendium
Menu

Issuer Credit Research

FWD Group Holdings Limited Issuer Flash: FY2025 Results

Issuer: Fwd | Document: Issuer Flash | Date: 2026-07-27 | Event: Fy2025 Results

Report date: 2026-07-27
Event date: 2026-03-16
Event title: FY2025 annual results
Issuer: FWD Group Holdings Limited
Ticker: FWDGHD (HKEX: 1828)
Sector: Pan-Asian life and health insurance / insurance holding company

Flash Conclusion

FWD's FY2025 results are credit positive in direction: new-business activity, operating earnings, IFRS 17 net profit, regulatory capital and holding-company funding flexibility all improved. APE rose 25% to US$2.446bn, new-business CSM rose 18% to US$1.476bn, value of new business (VNB) rose 11% to US$945m, and operating profit after tax (OPAT) attributable to equity holders increased 5% to US$499m. The group also reported a US$166m net profit, a 265% LCSM PCR cover ratio, US$1.612bn of holding-company liquidity resources and a lower 21.3% leverage ratio.

The results support the existing constructive view of FWD as an improving Asian insurance holding company with a growing franchise and better capital-market access after its 2025 listing. They do not eliminate the central structural constraint for holding-company creditors: insurance-subsidiary capital, contractual service margin (CSM), embedded value and group regulatory free surplus are not interchangeable with cash that can be upstreamed to service holding-company obligations. Net remittances of US$529m and the extension of the debt maturity profile are helpful, but future credit performance still depends on regulatory capital headroom and dividend capacity at operating subsidiaries, actual holding-company cash conversion, asset-liability management and continued access to funding.

The results also show that growth quality needs monitoring. Hong Kong & Macau was the principal engine, while group new-business margin declined and Thailand & Cambodia and Japan recorded weaker VNB trends. The reported 265% LCSM PCR cover ratio is strong, but the company disclosed a 210% pro-forma ratio after applying Japan's ESR framework. This remains a substantial capital ratio, but it is a useful reminder that regulatory methodology and local capital needs can materially affect headline group capital headroom.

FY2025 Results: Strong Growth, but Uneven Quality Across Markets

FWD's reported 2025 new-business indicators were robust. APE increased to US$2.446bn from US$1.916bn, new-business CSM increased to US$1.476bn from US$1.222bn, and VNB increased to US$945m from US$834m. CSM is important because it represents a stock of future accounting earnings to be released as insurance service is provided, but it should not be read as current liquidity for holding-company creditors. The same distinction applies to embedded value and comprehensive tangible equity: both improved in the disclosure, but neither is a direct measure of debt-service cash.

Hong Kong & Macau drove the group outcome. Its APE grew 51% to US$1.207bn, new-business CSM grew 64% to US$684m, and VNB grew 44% to US$478m. The contribution reflects demand across local and offshore business, including high-net-worth offerings and multichannel distribution. This supports the franchise, but also makes the group more exposed to the durability of the Hong Kong and Macau sales environment, product mix, margins, customer flows and distribution relationships.

Performance elsewhere was more mixed. Thailand & Cambodia's APE fell 6%, while new-business CSM and VNB fell 16% and 18%, respectively; management cited the exit from underwriting new corporate-care business and a lower-rate environment. Japan's APE and new-business CSM increased, but VNB fell 4%. Emerging Markets delivered 27% APE growth, while new-business CSM grew 4% and VNB 7%. At group level, new-business margin declined to 38.6% from 43.5%, and new-business CSM margin declined to 61.0% from 63.4%. These movements do not offset the positive headline earnings trend, but they show why APE growth alone is not an adequate measure of profitable, capital-efficient growth.

OPAT attributable to equity holders increased to US$499m from US$463m, while net profit attributable to equity holders rose to US$166m from US$24m. Each operating geographic segment made a positive OPAT contribution, although the corporate-and-other segment remained loss-making. The results announcement also reported net cash provided by operating activities of US$247m, down from US$526m. For an insurer, a single operating-cash-flow figure must be interpreted alongside liability movements, investments and operating-subsidiary remittances. Nonetheless, the decline reinforces the need to track conversion from reported earnings and value metrics into upstreamable funds.

Capital, Liquidity and Funding: Better, with Structural Limits

FWD reported a 265% group LCSM PCR cover ratio at end-2025, compared with 260% a year earlier, and group LCSM free surplus of US$4.833bn. The group reported US$7.766bn of available capital against a US$2.933bn prescribed capital requirement. These are material buffers under the local capital summation method, and the improvement was supported by business growth, foreign-exchange movements and reinsurance transactions. However, free surplus is a regulatory-capital metric, not cash freely available to the holding company, and capital availability can vary across regulated entities.

The Japan ESR transition is an important qualifier. FWD disclosed that, on a pro-forma basis after reflecting the Japan ESR framework, its group LCSM PCR cover ratio would be 210%, versus the reported 265%. Management did not expect further constraints on group financial flexibility or material changes in holding-company financial resources from the transition. The disclosure nevertheless demonstrates that the headline group ratio is sensitive to changes in local solvency methodology. Future reports should show whether the Japanese entity's capital position, product mix, investment risk and asset-liability management affect the capacity of the group to maintain capital headroom while growing.

Holding-company liquidity resources were US$1.612bn at year-end, slightly below US$1.656bn a year earlier, and included committed revolving facilities. Net remittances from operating subsidiaries were US$529m, compared with US$589m in 2024; the company attributed the lower amount chiefly to excess-capital remittance from Hong Kong & Macau after the implementation of Hong Kong RBC in 2024. The 2025 IPO generated gross proceeds of US$466m. FWD also refinanced loan facilities, refinanced US$900m of subordinated notes due 2029, and redeemed US$750m of perpetual capital securities. It issued US$575m of five-year and US$575m of ten-year subordinated dated capital securities. Leverage declined to 21.3% from 25.5%, moving closer to the company's 15-20% target range.

These actions improve the maturity profile and funding flexibility. The 2025 instruments are subordinated dated capital securities and should not be treated as equivalent to senior holding-company debt; the detailed contractual ranking, coupon-deferral mechanics, regulatory-capital treatment and investor protections of the outstanding instruments were not assessed in this flash. The financial strength of operating insurance subsidiaries should not be assumed to apply directly to holding-company creditors or to the subordinated instruments.

Credit Implications and Monitoring

The FY2025 disclosure strengthens the operating, capital and funding evidence supporting FWD's credit profile. The principal positive indicators are broader new-business generation, higher OPAT and net profit, continued regulatory-capital surplus, meaningful liquidity resources, subsidiary remittances and deleveraging after the IPO and refinancing.

The key limits to that conclusion are structural and execution-related. Holding-company debt service depends on distributable earnings and capital from subsidiaries after local regulatory requirements, not simply on consolidated CSM, embedded value or LCSM free surplus. The group also remains exposed to investment-market and insurance-liability risks, including rates, credit spreads, currencies, claims, persistency, guarantees, reinsurance and asset-liability management. Regional differences in VNB and margins mean that the durability of Hong Kong & Macau growth, Thailand & Cambodia recovery, Japan ESR implementation and Emerging Markets profitability all matter.

The next review should confirm: (1) interim 2026 CSM, VNB, OPAT, capital and cash-flow trends; (2) subsidiary-level solvency and remittance capacity; (3) the realised impact of Japan ESR on capital flexibility; (4) investment-portfolio quality and ALM sensitivity; (5) ratings-agency actions and sensitivities; and (6) leverage, liquidity, debt maturities and the detailed contractual terms and market performance of the subordinated dated capital securities before a security-specific investment decision.

Sources